Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between functional impairment, depression, and extrapyramidal signs in neuroleptic-free patients with Alzheimer disease.

Journal of geriatric psychiatry and neurology - 1 Sept 2013

Choi Junbae, Myung Woojae, Chung Jae Won, Kang Hyo Shin, Na Duk L, Kim Seong Yoon, Lee Jae-Hong, Han Seol-Heui, Choi Seong Hye, Kim Sangyun, Kim Seonwoo, Carroll Bernard J, Kim Doh Kwan

Abstract excerpt

BACKGROUND: Extrapyramidal signs (EPSs) are commonly observed in patients with Alzheimer disease (AD). We report here the base rate of EPS in a large cohort of patients with AD who were not receiving neuroleptic drugs, and the associations of EPS with functional outcomes and depressive symptoms....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activities of Daily Living
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Basal Ganglia Diseases

Share to Data Interpretation, Statistical

Share to Depression

Share to Geriatric Assessment

Share to Neurologic Examination

Share to Republic of Korea

Source

Identifiers

PMID: 23733855
DOI: 10.1177/0891988713490993

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23733855-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between functional impairment, depression, and extrapyramidal signs in neuroleptic-free patients with Alzheimer disease.PMID 23733855Read ↗

Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer’s DementiaSemantic proximity Read ↗

Incidence and subtypes of early-onset dementia in a geographically defined general populationSemantic proximity Read ↗

Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.Semantic proximity Read ↗

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.Semantic proximity Read ↗

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s diseaseSemantic proximity Read ↗

Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.Semantic proximity Read ↗

The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.Semantic proximity Read ↗

Comparing phenotypic features between Parkinson's disease dementia and dementia with Lewy bodies.Semantic proximity Read ↗

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.Semantic proximity Read ↗

Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypesSemantic proximity Read ↗

Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.Semantic proximity Read ↗

Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.